Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity

American Journal of Pathology

Volumn 160, Issue 4, 2002, Pages 1251-1257

  Baege, Astrid C ^a   Berger, Allison ^b   Schlegel, Robert ^b   Veldman, Tim ^a   Schlegel, Richard ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; ONCOPROTEIN; PROTEIN E6; PROTEIN E7; RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; UTERINE CERVIX EPITHELIUM; VIRUS ONCOGENE;

EID: 0036110509     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62552-7     Document Type: Article

References (33)

1. Papillomavirus infections - A major cause of human cancers
2. Papillomavirus causing cancer: Evasion from host-cell control in early events in carcinogenesis
3. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
4. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product
5. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
6. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18
7. Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16
8. The E6 and E7 genes of human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes
9. Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma
10. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer
11. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: Strong association with elevated messenger RNA levels of its catalytic subunit and high risk human papillomavirus DNA
12. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
13. Extension of life span by introduction of telomerase into normal human cells
14. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit telomerase
15. Telomerase activation by the E6 gene product of human papillomavirus type 16
16. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein
17. E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc
18. Specific association of human telomerase with immortal cells and cancer
19. Telomerase activation in cervical cancer
20. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappa-responsive genes in cervical keratinocytes
21. Telomerase catalytic subunit homologs from fission yeast and human
22. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO
23. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length
24. Telomerase activity in a specific cell subset co-expressing integriβ1/EGFR but not p75NGFR/bc12/integrin beta4 in normal human epithelial cells
25. Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: Activation of telomerase and allele losses at 3p, 10p, 11p, 11q and/or 18q
26. Telomerase activation by human papillomavirus type 16 E6 protein: Induction of human telomerase reverse transcriptase expression through myc and GC-rich spl binding sites
27. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis
28. Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer
29. Telomerase activity in normal human epithelial cells
30. Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix
31. Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smears
32. Telomerase activity and expression of its RNA component in cervical lesions
33. Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions